Nurjana Bachman

As Chief Business Officer, Nurjana is responsible for Claritas’s business development and partnering. Prior to co-founding Claritas, Nurjana was Associate Director of Strategic Initiatives and Business Development in the Technology and Innovation Development Office (TIDO) at Boston Children’s Hospital. In that capacity she facilitated partnerships between BCH and other entities to support BCH’s clinical and research mission, including the Life Technologies investment that resulted in Claritas. In addition Nurjana facilitated transactions with Shire to support rare disease research and Pfizer to develop bio-therapeutics. As a Licensing Manager at TIDO, she managed several hundred patents and was involved in over 100 transactions, including launching a start-up, licensing agreements, collaborations, material transfer agreements, and confidentiality agreements.

Nurjana was awarded her BA in Biology with distinction from Swarthmore College and her PhD in Molecular Biology and Genetics from the Johns Hopkins University School of Medicine.